How PX1 Tests Every Dihexa Lot (HPLC, MS, Endotoxin)

Rigorous analytical validation is essential when evaluating specialized synthetic oligopeptide derivatives for laboratory research. PX1 Research executes a comprehensive, lot-by-lot testing protocol for every batch of dihexa third party tested material to confirm exact molecular identity, high chromatographic purity, and strict endotoxin compliance. This breakdown explains our multi-stage quality stack—from mass spectrometry and high-performance liquid chromatography to lot-matched Certificate of Analysis (COA) verification.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Rigorous analytical validation is essential when evaluating specialized synthetic oligopeptide derivatives for laboratory research. PX1 Research executes a comprehensive, lot-by-lot testing protocol for every batch of dihexa third party tested material to confirm exact molecular identity, high chromatographic purity, and strict endotoxin compliance. This breakdown explains our multi-stage quality stack—from mass spectrometry and high-performance liquid chromatography to lot-matched Certificate of Analysis (COA) verification.

Reviewed by PX1 Research scientific team

Key takeaways

  • [Dihexa](/research-peptides/dihexa) (N-hexanoic-Tyr-Ile-(6-aminohexanoic acid) amide) is an oligopeptide derivative designed as an orally stable, lipophilic analog derived from Angiotensin IV.
  • Custom organic synthesis of complex peptide derivatives often yields side products, including truncated sequences, incomplete hexanoyl coupling fragments, residual trifluoroacetic acid (TFA), and trace organic solvents.
  • Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary tool for quantifying chemical purity.
  • While HPLC confirms that a sample is free of co-eluting chemical impurities, it cannot verify exact atomic composition.

Overview of Dihexa in Laboratory Research Contexts

Dihexa (N-hexanoic-Tyr-Ile-(6-aminohexanoic acid) amide) is an oligopeptide derivative designed as an orally stable, lipophilic analog derived from Angiotensin IV. In preclinical models, researchers investigate its affinity for Hepatocyte Growth Factor (HGF) and its tyrosine kinase receptor, c-Met. In vitro assays and animal studies suggest that activation of the HGF/c-Met signaling cascade plays a role in synaptogenesis, dendritic arborization, and cellular repair pathways.

Because small structural deviations or leftover synthetic precursors can obscure experimental outcomes, obtaining a verified reference standard is critical. PX1 Research supplies Dihexa strictly as a research-grade chemical for in vitro and laboratory experimentation. To explore our broader inventory of analytical-grade reference material, researchers can browse our complete catalog of all peptides and synthesized small molecules.

The Necessity of Multi-Tiered Analytical Lot Testing

Custom organic synthesis of complex peptide derivatives often yields side products, including truncated sequences, incomplete hexanoyl coupling fragments, residual trifluoroacetic acid (TFA), and trace organic solvents. Relying solely on a single analytical metric—such as basic UV absorbency—can miss major impurities that alter binding kinetics or cause off-target toxicity in cell culture models.

To eliminate batch-to-batch variability, PX1 Research implements an independent quality assurance pipeline. Every lot undergoes orthogonal testing: reverse-phase high-performance liquid chromatography (RP-HPLC) for chromatographic purity, electrospray ionization mass spectrometry (ESI-MS) for absolute molecular identity, and Limulus Amebocyte Lysate (LAL) testing for endotoxin screening. This multi-layered screening ensures that investigators receive reference material matching exact theoretical specifications.

Reverse-Phase HPLC (RP-HPLC): Purity & Area Percent Determination

Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary tool for quantifying chemical purity. During this assay, the Dihexa sample is dissolved in an appropriate mobile phase and injected onto a hydrophobic stationary phase (typically a C18 silica column). A gradient elution using water, acetonitrile, and an ion-pairing agent (such as 0.1% TFA) separates the target molecule from related synthesis impurities based on hydrophobicity.

Detection is conducted via UV spectrophotometry, typically monitored at 214 nm (peptide backbone absorbency) and 254 nm (aromatic ring absorbency). The resulting chromatogram integrates the area under each peak. To pass PX1 quality controls, the primary target peak for Dihexa must meet or exceed a 98.0% area percent threshold, ensuring minimal interference from deletion sequences or oxidized chemical byproducts in downstream analytical assays.

Mass Spectrometry (ESI-MS): Molecular Weight & Structural Verification

While HPLC confirms that a sample is free of co-eluting chemical impurities, it cannot verify exact atomic composition. PX1 utilizes Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) to confirm the exact monoisotopic mass of each batch. The theoretical mass-to-charge (m/z) ratio of Dihexa is calculated based on its chemical structure ($C_{27}H_{44}N_{4}O_{5}$, target monoisotopic mass approximately 504.66 g/mol).

The mass spectrometer ionizes the sample and measures the resultant ions against established reference standards. A passing result requires the primary observed peak to match the expected molecular weight within a strict mass tolerance (typically ±0.5 Da). This step prevents mislabeled compounds, incorrect counter-ion salts, or structurally modified analogs from reaching the laboratory setup. Analytical documentation verifying mass identity can be inspected directly on our dedicated COA lookup portal.

Quantifying Peptide Content vs. Chromatographic Purity

A common point of confusion in raw research material evaluation is the distinction between chromatographic purity percentage and total peptide content (also known as net peptide weight). HPLC purity indicates the proportion of the target compound relative to total UV-absorbing species. However, lyophilized powders inherently retain non-peptide components, including residual moisture and counter-ions like acetate or trifluoroacetate.

To establish precise mass calculations for cell culture media or quantitative biochemical assays, PX1 measures actual peptide content via Elemental Analysis (CHN) or Nitrogen Analysis. If a lot exhibits 99% HPLC purity but a 85% net peptide content, the remaining 15% consists of counter-salts and trace moisture. Understanding this metric allows principal investigators to calibrate experimental concentrations accurately without overestimating actual compound exposure.

LAL Endotoxin Assay: Safeguarding Cellular Assays

Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent biological pyrogens. In cell culture, stem cell assays, or animal tissue explant studies, minute concentrations of endotoxin can trigger unwanted inflammatory cascades, alter receptor expression, and invalidate experimental conclusions.

PX1 subjects every lot of Dihexa to a chromogenic or turbidimetric Limulus Amebocyte Lysate (LAL) assay performed by an accredited laboratory. We enforce strict endotoxin limits (typically < 0.05 EU/mg), ensuring that the material is suited for sensitive in vitro tissue models without introducing confounding immune responses. Each lot’s exact endotoxin score is printed directly on its accompanying documentation.

Sterility Verification & Residual Solvent Screening

In addition to purity and endotoxin assays, volatile organic compounds used during peptide synthesis and purification (such as dichloromethane, dimethylformamide, and acetonitrile) must be thoroughly removed. Residual solvent analysis is performed via Gas Chromatography paired with Headspace sampling (GC-HS) to confirm that residual organic solvents fall well below established safety guidelines.

For specialized laboratory preparations, such as our standardized Dihexa 10mg research format, rigorous sterility and mass uniformity checks are implemented. Automated filling procedures operate under HEPA-filtered ISO Class 5 cleanroom conditions to prevent ambient environmental contamination, preserving compound integrity across long-term storage intervals.

Matching Lot Identifiers: COA Traceability Protocol

Transparency requires absolute traceability between the analytical certificate and the physical container in the laboratory. PX1 assigns a unique, sequential batch and lot number to every production run. This identifier is permanently etched or printed on both the primary container label and the outer packaging.

To verify a batch, researchers enter the lot code into the PX1 testing database to access full-resolution HPLC chromatograms, mass spectra, and LAL assay outputs. Researchers can cross-reference physical vials with their corresponding batch records via our transparent COA database, ensuring full accountability prior to initiating delicate experimental protocols.

Comparative Analysis: Dihexa Relative to Other Cognitive Research Compounds

When designing neuro-biochemical models, researchers often evaluate Dihexa alongside other synthetic compounds targeting distinct signaling axes. For example, while Dihexa primary literature focuses on the HGF/c-Met axis, researchers studying peptide-mediated neuroprotective pathways may also examine Semax, which modulates BDNF and trkB expression in preclinical rodent models. Similarly, Selank is frequently evaluated in neuro-immunology research for its effects on enkephalin degradation and cytokine expressions.

Another distinct reference molecule in central nervous system literature is Noopept, an N-acyl-prolyl-glycine ester that acts via cholinergic and AMPA receptor pathways rather than tyrosine kinase receptor pathways. The table below summarizes key analytical parameters across these reference compounds:

Laboratory Handling, Solubilization, and Reconstitution Protocol

Dihexa is a hydrophobic synthetic peptide derivative. Unlike highly hydrophilic linear peptides, its solubility profile requires careful solvent selection depending on the target assay system. For cell culture applications, stock solutions are typically prepared using research-grade dimethyl sulfoxide (DMSO) or ethanol, followed by step-down dilution into aqueous buffer systems (such as PBS or culture media) to avoid compound precipitation.

Lyophilized solid material should be stored desiccated at -20°C to minimize long-term hydrolytic degradation. Once reconstituted, stock solutions should be aliquot-frozen to avoid repeated freeze-thaw cycles. Laboratories planning volumetric calculations or dilution series can utilize our free reconstitution calculator to determine precise molarities and solvent ratios for their experimental protocols.

PX1 Supply Chain & Quality Infrastructure: ISO 17025 Standards

PX1 Research operates with a focus on manufacturing integrity and quality assurance. All dihexa third party tested inventory is synthesized in cGMP-compliant facilities and subjected to analytical verification in independent ISO/IEC 17025 accredited laboratories located within the United States.

By maintaining fulfillment operations out of optimized logistics centers in California and Arizona, PX1 offers rapid dispatch with same-day shipping on orders placed Monday through Friday before 3:00 PM EST. For institutions requiring high-volume orders or specialized custom packaging configurations, detail can be coordinated via our dedicated wholesale lab accounts hub. Explore our expanded research library hub for further technical documentation.

Frequently Asked Questions

What testing methods verify that PX1 Dihexa is third-party tested?

Every lot of Dihexa undergoes independent, third-party testing utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity quantification, Electrospray Ionization Mass Spectrometry (ESI-MS) for mass verification, and Limulus Amebocyte Lysate (LAL) assays for endotoxin detection.

How do I cross-reference my vial lot code with the COA?

Each vial features a unique lot code on its label. Enter this lot number into the PX1 COA lookup portal to view and download the exact analytical certificate, HPLC chromatogram, and mass spectrum corresponding to your physical batch.

Why is endotoxin testing necessary for Dihexa in laboratory settings?

Endotoxins (LPS) induce strong immune and inflammatory responses in cell culture models, which can cause cytotoxicity or confound experimental data. Testing ensures endotoxin levels remain below 0.05 EU/mg for sensitive in vitro research.

What is the difference between chromatographic purity and peptide content?

Chromatographic purity (measured by HPLC) indicates the percentage of target compound relative to chemical impurities. Net peptide content accounts for counter-ions (like TFA or acetate) and residual moisture bound to the powder, reflecting the true active compound mass.

What solvents are suitable for reconstituting Dihexa for in vitro experiments?

Due to its lipophilic structure, Dihexa usually requires initial dissolution in organic solvents such as research-grade DMSO or ethanol before dilution into aqueous buffers like PBS or culture medium.

Is PX1 Dihexa manufactured and tested in the USA?

Yes, PX1 Dihexa is manufactured in cGMP-compliant facilities and tested by ISO 17025 accredited analytical laboratories within the United States.

How should raw Dihexa powder be stored long term?

Desiccated raw Dihexa powder should be stored sealed at -20°C in a dry environment protected from light to maintain chemical stability and prevent hydrolysis over extended periods.

Does PX1 provide analytical tools for preparing stock concentrations?

Yes, researchers can utilize the online PX1 reconstitution calculator to compute exact volumetric dilutions, solvent proportions, and working molar concentrations for laboratory use.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.